Aurora Investment Counsel’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.02M | Buy |
+29,260
| New | +$2.02M | 1.06% | 41 |
|
|
2022
Q1 | – | Sell |
-27,614
| Closed | -$1.55M | – | 130 |
|
|
2021
Q4 | $1.55M | Sell |
27,614
-3,458
| -11% | -$194K | 0.92% | 44 |
|
|
2021
Q3 | $1.49M | Sell |
31,072
-3,020
| -9% | -$145K | 1.04% | 36 |
|
|
2021
Q2 | $1.43M | Buy |
34,092
+266
| +0.8% | +$11.1K | 1% | 42 |
|
|
2021
Q1 | $1.14M | Buy |
33,826
+278
| +0.8% | +$9.37K | 0.84% | 62 |
|
|
2020
Q4 | $1.17M | Sell |
33,548
-16
| -0% | -$559 | 0.94% | 47 |
|
|
2020
Q3 | $1.12M | Sell |
33,564
-214
| -0.6% | -$7.14K | 0.92% | 47 |
|
|
2020
Q2 | $1.11M | Sell |
33,778
-4,180
| -11% | -$137K | 1.05% | 33 |
|
|
2020
Q1 | $1.14M | Sell |
37,958
-4,408
| -10% | -$133K | 1.26% | 15 |
|
|
2019
Q4 | $1.23M | Sell |
42,366
-19,848
| -32% | -$574K | 0.92% | 46 |
|
|
2019
Q3 | $1.61M | Sell |
62,214
-1,430
| -2% | -$37K | 0.78% | 71 |
|
|
2019
Q2 | $1.53M | Buy |
63,644
+4,234
| +7% | +$101K | 0.73% | 83 |
|
|
2019
Q1 | $1.55M | Buy |
+59,410
| New | +$1.55M | 0.77% | 74 |
|
|
2014
Q4 | $1.86M | Sell |
88,004
-3,030
| -3% | -$64.1K | 1.15% | 45 |
|
|
2014
Q3 | $2.17M | Sell |
91,034
-13,692
| -13% | -$326K | 1.42% | 13 |
|
|
2014
Q2 | $2.42M | Buy |
104,726
+2,950
| +3% | +$68.1K | 1.52% | 7 |
|
|
2014
Q1 | $2.32M | Sell |
101,776
-12,384
| -11% | -$283K | 1.49% | 5 |
|
|
2013
Q4 | $2.11M | Buy |
+114,160
| New | +$2.11M | 1.39% | 20 |
|